Scott E. Martin

Affiliations: 
2004 Pennsylvania State University, State College, PA, United States 
Google:
"Scott Martin"
Mean distance: 8.75
 
SNBCP

Parents

Sign in to add mentor
Blake R. Peterson grad student 1998-2004 Penn State
 (Synthesis and evaluation of synthetic cell surface receptors and related biological probes)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ding X, Chaudhuri AR, Callen E, et al. (2016) Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies. Nature Communications. 7: 12425
Fogel AI, Martin SE, Hasson SA. (2016) Application of Imaging-Based Assays in Microplate Formats for High-Content Screening. Methods in Molecular Biology (Clifton, N.J.). 1439: 273-304
Grohar PJ, Kim S, Rangel Rivera GO, et al. (2016) Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma. Cell Reports
Bogen D, Wei JS, Azorsa DO, et al. (2015) Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma. Oncotarget
Sivan G, Ormanoglu P, Buehler EC, et al. (2015) Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant. Mbio. 6
Hasson SA, Fogel AI, Wang C, et al. (2015) Chemogenomic profiling of endogenous PARK2 expression using a genome-edited coincidence reporter. Acs Chemical Biology. 10: 1188-97
Xiao S, Chen YC, Betenbaugh MJ, et al. (2015) MiRNA mimic screen for improved expression of functional neurotensin receptor from HEK 293 cells. Biotechnology and Bioengineering. 112: 1632-43
Siebert M, Westbroek W, Chen YC, et al. (2014) Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells. Rna Biology. 11: 1291-300
Jossé R, Martin SE, Guha R, et al. (2014) ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses. Cancer Research. 74: 6968-79
Ou O, Huppi K, Chakka S, et al. (2014) Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity. Cancer Letters. 354: 336-47
See more...